Dynamics of leukocyte inflammatory markers in patients with ST-elevation myocardial infarction depending on left ventricle ejection fraction
DOI:
https://doi.org/10.14739/2310-1237.2022.3.267268Keywords:
leukocytes, markers of inflammation, ST segment elevation myocardial infarctionAbstract
Aim: to evaluate the dynamics of leukocyte inflammatory markers in patients with ST-elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) depending on ejection fraction of left ventricular (LV).
Material and methods. The study group consisted of 23 consecutive patients with STEMI admitted to the Regional Clinical Cardiology Center in Chernivtsi, who underwent successful reperfusion treatment by PCI. To evaluate inflammatory markers, a complete blood count (CBC) was assessed at admission, and on day 10 of hospital stay on the background of optimal drug therapy.
Results. It was found that patients with STEMI and reduced left ventricular ejection fraction (LVEF) (group 2) at admission had a significantly higher leukocyte count (P < 0.05) and an increase in the absolute neutrophils (P < 0.01) with significantly higher inflammatory markers: neutrophil-to-lymphocyte ratio (NLR) (P < 0.01), monocyte-to-lymphocyte ratio (MLR), systemic immune inflammation index (SII) (P < 0.01), systemic inflammation response index (SIRI) (P < 0.01), aggregate index of systemic inflammation (AISI) (P < 0.05), and integrated index of inflammation (III) (P < 0.05). On day 10 of treatment, the analysis of inflammatory markers showed that in patients of group 2, NLR (P < 0.01) and SII (P < 0.05) remained significantly higher than in STEMI patients with preserved LVEF (group 1). At the study of the changes in leukocyte-based inflammatory markers in STEMI patients under the influence of optimal drug therapy after PCI, a decrease (P < 0.05) in NLR, MLR, SII, SIRI, IIII, and an increase in (P < 0.05) LMR were observed.
Conclusions. CBC of inflammatory markers at admission identifies the risk of adverse cardiovascular events and determines measures to regulate the activity of the inflammatory process in STEMI.
References
- Si, Y., Liu, J., Shan, W., Zhang, Y., Han, C., Wang, R., & Sun, L. (2020). Association of lymphocyte-to-monocyte ratio with total coronary plaque burden in patients with coronary artery disease. Coronary artery disease, 31(7), 650-655. https://doi.org/10.1097/MCA.0000000000000857
- Dziedzic, E. A., Gąsior, J. S., Tuzimek, A., Dąbrowski, M., & Jankowski, P. (2022). Neutrophil-to-Lymphocyte Ratio Is Not Associated with Severity of Coronary Artery Disease and Is Not Correlated with Vitamin D Level in Patients with a History of an Acute Coronary Syndrome. Biology, 11(7), 1001. https://doi.org/10.3390/biology11071001
- Yoon, G. S., Choi, S. H., Woo, S. I., Baek, Y. S., Park, S. D., Shin, S. H., Kim, D. H., Kwan, J., Lee, M. J., & Kwon, S. W. (2021). Neutrophil-to-Lymphocyte Ratio at Emergency Room Predicts Mechanical Complications of ST-segment Elevation Myocardial Infarction. Journal of Korean medical science, 36(19), e131. https://doi.org/10.3346/jkms.2021.36.e131
- Fonseca, F. A., & Izar, M. C. (2022). Role of Inflammation in Cardiac Remodeling After Acute Myocardial Infarction. Frontiers in physiology, 13, 927163. https://doi.org/10.3389/fphys.2022.927163
- Tavares, F., Moraes, P. I. M., Souza, J. M., Barbosa, A. H., Santos, E. M., Marcondes, J. A., Oliveira, M. D., Gonçalves, I., Jr, Espírito Santo, C. V. A., Bianco, H. T., Fonseca, F. A. H., Moisés, V., & Caixeta, A. (2022). Prognostic role of neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing to pharmaco-invasive strategy. Cardiovascular revascularization medicine : including molecular interventions, 34, 99-103. https://doi.org/10.1016/j.carrev.2021.01.027
- Anzai, A., Ko, S., & Fukuda, K. (2022). Immune and Inflammatory Networks in Myocardial Infarction: Current Research and Its Potential Implications for the Clinic. International journal of molecular sciences, 23(9), 5214. https://doi.org/10.3390/ijms23095214
- Kovalenko, V., Dolzhenko, M., & Potashev, S. (2018). Nastanovy z klinichnoi ekhokardiohrafii [Guidelines for clinical echocardiography]. Kyiv: Naukova dumka. [in Ukrainian].
- Li, Q., Ma, X., Shao, Q., Yang, Z., Wang, Y., Gao, F., Zhou, Y., Yang, L., & Wang, Z. (2022). Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients. Frontiers in cardiovascular medicine, 9, 811790. https://doi.org/10.3389/fcvm.2022.811790
- Dai, K., Li, Z., Luo, Y., Xiong, Q., Xiong, Y., Song, Z., & Xiong, W. (2022). The Predictive Value of the Monocyte-to-Lymphocyte Ratio and Monocyte-to-Haematocrit Ratio for Cardiac Rupture Patients with Acute Myocardial Infarction: A Propensity Score Matching Analysis. Risk management and healthcare policy, 15, 37-44. https://doi.org/10.2147/RMHP.S348894
- Urbanowicz, T., Michalak, M., Olasińska-Wiśniewska, A., Rodzki, M., Witkowska, A., Gąsecka, A., Buczkowski, P., Perek, B., & Jemielity, M. (2022). Neutrophil Counts, Neutrophil-to-Lymphocyte Ratio, and Systemic Inflammatory Response Index (SIRI) Predict Mortality after Off-Pump Coronary Artery Bypass Surgery. Cells, 11(7), 1124. https://doi.org/10.3390/cells11071124
- Han, K., Shi, D., Yang, L., Wang, Z., Li, Y., Gao, F., Liu, Y., Ma, X., & Zhou, Y. (2022). Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Annals of medicine, 54(1), 1667-1677. https://doi.org/10.1080/07853890.2022.2083671
- Bao, K., Huang, H., Huang, G., Wang, J., Liao, Y., Pan, Y., Chen, W., Lu, J., Yang, Y., Huang, Z., Chen, S., Chen, K., & Chen, L. (2021). Platelet-to-hemoglobin ratio as a valuable predictor of long-term all-cause mortality in coronary artery disease patients with congestive heart failure. BMC cardiovascular disorders, 21(1), 618. https://doi.org/10.1186/s12872-021-02423-6
- Libby P. (2021). Inflammation in Atherosclerosis-No Longer a Theory. Clinical chemistry, 67(1), 131-142. https://doi.org/10.1093/clinchem/hvaa275
- Chan, Y. H., & Ramji, D. P. (2020). A perspective on targeting inflammation and cytokine actions in atherosclerosis. Future medicinal chemistry, 12(7), 613-626. https://doi.org/10.4155/fmc-2019-0301
- King, A. H., Kwan, S., Schmaier, A. H., Kumins, N. H., Harth, K. C., Colvard, B. D., Wong, V. L., Kashyap, V. S., & Cho, J. S. (2021). Elevated neutrophil to lymphocyte ratio is associated with decreased amputation-free survival after femoropopliteal percutaneous revascularization. International angiology, 40(5), 442-449. https://doi.org/10.23736/S0392-9590.21.04699-X
- Zhang, S., Diao, J., Qi, C., Jin, J., Li, L., Gao, X., Gong, L., & Wu, W. (2018). Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC cardiovascular disorders, 18(1), 75. https://doi.org/10.1186/s12872-018-0812-6
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.





